Management of Antibiotic-Induced Diarrhea
The management of antibiotic-induced diarrhea should begin with discontinuation of the offending antibiotic when possible, followed by supportive care with hydration and dietary modifications, and specific treatment based on severity and etiology. 1
Assessment and Classification
- Evaluate the severity of diarrhea based on frequency, volume, consistency, and presence of blood or mucus 1
- Assess for signs of dehydration, fever, abdominal pain, or weakness which may indicate severe disease or complications 1
- Consider testing for Clostridioides difficile (formerly Clostridium difficile) infection, which accounts for 10-20% of all antibiotic-associated diarrhea cases 2
- Rule out other infectious causes, especially in severe or persistent cases 1
Initial Management
Supportive Care
- Ensure adequate hydration with oral rehydration solutions or intravenous fluids if dehydration is severe 1
- Implement dietary modifications:
- Monitor and record the number of stools and report symptoms of life-threatening sequelae 1
Pharmacological Management
- For mild to moderate diarrhea without fever or bloody stools:
- Antimotility drugs should be avoided in cases of suspected or proven inflammatory diarrhea or diarrhea with fever 1
Management of Specific Causes
Clostridioides difficile Infection (CDI)
- If C. difficile infection is confirmed or strongly suspected:
- Implement appropriate infection control measures including hand hygiene and contact precautions 1
Non-C. difficile Antibiotic-Associated Diarrhea
- Consider probiotics to reduce symptom severity and duration 1
- For persistent diarrhea despite initial management:
Prevention Strategies
- Use antibiotics judiciously and select narrow-spectrum agents when possible 7
- Consider prophylactic probiotics when initiating antibiotic therapy, especially for high-risk patients 2
- Maintain good hand hygiene to prevent transmission of C. difficile and other pathogens 1
Special Considerations
- For immunocompromised patients with severe illness and bloody diarrhea, empiric antibacterial treatment should be considered 1
- In cancer patients receiving chemotherapy who develop diarrhea, octreotide (100-150 μg SC TID) may be considered for severe cases not responding to loperamide 1
- Avoid antimotility agents in suspected toxic megacolon or inflammatory bowel conditions 1
Common Pitfalls to Avoid
- Continuing the offending antibiotic unnecessarily when alternatives are available 5
- Using antimotility agents in cases of inflammatory or infectious diarrhea with fever 1
- Failing to test for C. difficile in patients with persistent or severe diarrhea 2
- Overlooking dehydration and electrolyte imbalances, which require prompt correction 1